- Home
- BLDEW vs ITUB Comparison
BLDEW vs ITUB Comparison
Compare BLDEW & ITUB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLDEW
- ITUB
- Stock Information
- Founded
- BLDEW 2014
- ITUB 1924
- Country
- BLDEW United States
- ITUB Brazil
- Employees
- BLDEW 281
- ITUB N/A
- Industry
- BLDEW Transportation Services
- ITUB Major Banks
- Sector
- BLDEW Consumer Discretionary
- ITUB Finance
- Exchange
- BLDEW Nasdaq
- ITUB Nasdaq
- Market Cap
- BLDEW N/A
- ITUB N/A
- IPO Year
- BLDEW N/A
- ITUB N/A
- Fundamental
- Price
- BLDEW $0.34
- ITUB $5.73
- Analyst Decision
- BLDEW
- ITUB Strong Buy
- Analyst Count
- BLDEW 0
- ITUB 3
- Target Price
- BLDEW N/A
- ITUB $6.90
- AVG Volume (30 Days)
- BLDEW 51.0K
- ITUB 27.8M
- Earning Date
- BLDEW 03-13-2025
- ITUB 02-05-2025
- Dividend Yield
- BLDEW N/A
- ITUB 6.57%
- EPS Growth
- BLDEW N/A
- ITUB 24.07
- EPS
- BLDEW N/A
- ITUB 0.67
- Revenue
- BLDEW $241,814,000.00
- ITUB $21,946,838,321.00
- Revenue This Year
- BLDEW N/A
- ITUB N/A
- Revenue Next Year
- BLDEW N/A
- ITUB $6.93
- P/E Ratio
- BLDEW N/A
- ITUB $7.98
- Revenue Growth
- BLDEW 12.04
- ITUB 9.00
- 52 Week Low
- BLDEW $0.30
- ITUB $4.86
- 52 Week High
- BLDEW $0.36
- ITUB $7.07
- Technical
- Relative Strength Index (RSI)
- BLDEW N/A
- ITUB 50.53
- Support Level
- BLDEW N/A
- ITUB $5.78
- Resistance Level
- BLDEW N/A
- ITUB $6.12
- Average True Range (ATR)
- BLDEW 0.00
- ITUB 0.11
- MACD
- BLDEW 0.00
- ITUB -0.03
- Stochastic Oscillator
- BLDEW 0.00
- ITUB 17.02
About BLDEW Blade Air Mobility Inc.
Blade Air Mobility Inc is a technology-powered air mobility platform that provides air transportation and logistics for hospitals and is a transporter of human organs for transplant, and for passengers, with helicopter and fixed-wing services predominantly in the Northeast United States, Southern Europe and Western Canada. The company's operating segments are; Passenger, and Medical. Majority of the revenue for the company is generated from its Medical segment which predominantly consists of transportation of human organs for transplant and the medical teams supporting these services. It also offers additional services including donor logistics coordination and support in evaluating potential donor organs. A substantial portion of the company's revenue is generated from the United States.